Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study

Abstract

BackgroundSeveral studies have reported that the combination of high TG and low HDL-C, as simplified by the TG/HDL-C ratio, was a predictor of cardiovascular disease independent of LDL-C level. Nevertheless, poor data are available on the predictive role of TG/HDL-C ratio in very high risk (VHR) patients with chronic coronary syndromes (CCS).MethodsUsing the data from the STable Coronary Artery Diseases RegisTry (START) study, an Italian nationwide registry, we assessed the association between the TG/HDL-C ratio and baseline clinical characteristics, pharmacological treatment, and major adverse cardio-cerebrovascular events (MACCE) at 1 year in a large cohort of CCS patients at VHR.ResultsVHR patients with both TG and HDL-C levels available were grouped in tertiles of TG/HDL-C ratio: low (TG/HDL-C ratio <2, n = 967), middle (TG/HDL-C ratio 2–3.3, n = 1,071) and high (TG/HDL-C ratio >3.3, n = 1,028). At 1 year from enrolment, 232 (7.6%) patients presented a MACCE, with a higher incidence in the higher tertile, even though not statistically significant (6.0, 8.2, and 8.4% in the low, middle and high tertile, respectively; p = 0.08). At multivariable analysis, the TG/HDL-C ratio in tertiles did not result an independent predictor of the MACCE (p = 0.29) at 1-year follow-up (HR: 1.30; 95% CI: 0.93–1.82; p = 0.12 middle vs. lower tertile, and HR: 1.22; 95% CI: 0.87–1.72; p = 0.25 higher vs. lower).ConclusionsIn the present large, nationwide cohort of CCS patients at VHR a high TG/HD ratio did not emerge as independent predictor of MACCE at 1 year. Further studies with a longer follow-up are needed to better define the prognostic role of TG/HDL ratio in CCS.

Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease

“…Comparable results were reported for TG/HDL-C, which predicts worse outcomes in patients with acute coronary syndrome and ischemic stroke [54][55][56][57][58][59][60], with wide heterogeneity in its predictive value across different ethnicities [48]. Data regarding the relationship between LAP and VAI showed a significant association with both the short-and long-term risk of CVEs in nonobese patients [49][50][51].…”

Molecular imaging research in atherosclerosis: A 23-year scientometric and visual analysis

“…Furthermore, overlay view and citations bursts detection are two of the central methods for tracing the evolution of science ( Yuan et al, 2021 ). The treatment of cardio-cerebrovascular diseases caused by AS is a major global health concern ( De Luca et al, 2022 ), and the application of molecular imaging will have a profound impact on the early diagnosis and precise treatment of AS ( Lin et al, 2021 ; Wang et al, 2021 ). Figure 7A shows that the research was divided into five clusters which constructed the knowledge structures in this field: (1) Nanoparticle-related studies.…”

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study

“…Many studies have shown that not only the index blood lipid level, but also their variabilities and controlling levels after discharge are of great significance to the secondary prevention and long-term prognosis of cardiovascular disease (2)(3)(4)(5). In addition to low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride, several novel lipoprotein ratios have been proved with greater predictive power in cardiovascular prevention, especially the LDL-C to HDL-C ratio (LHR), which could reflect not only the atherogenic lipoprotein, but also the protective lipoprotein and their balance (6)(7)(8)(9). Jesús Millán et al pointed out that LHR was more predictive of cardiovascular disease risk than either lipoprotein alone (9).…”